{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:33:59Z","timestamp":1760243639881,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10147-022-02168-y","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T14:03:12Z","timestamp":1650549792000},"page":"1202-1211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey"],"prefix":"10.1007","volume":"27","author":[{"given":"Selma","family":"Metintas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8849-193X","authenticated-orcid":false,"given":"Guntulu","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Metintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"6","key":"2168_CR1","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/ijc.32931","volume":"147","author":"E Sirri","year":"2020","unstructured":"Sirri E, Kieschke J, Vohmann C et al (2020) GEKID cancer survival working group, survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: a population-based study. Int J Cancer 147(6):1548\u20131558. https:\/\/doi.org\/10.1002\/ijc.32931","journal-title":"Int J Cancer"},{"issue":"11","key":"2168_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/ijerph14111293","volume":"14","author":"S Metinta\u015f","year":"2017","unstructured":"Metinta\u015f S, Bat\u0131rel HF, Bayram H et al (2017) Turkey national mesothelioma surveillance and environmental asbestos exposure control program. Int J Environ Res Public Health 14(11):1293. https:\/\/doi.org\/10.3390\/ijerph14111293","journal-title":"Int J Environ Res Public Health"},{"key":"2168_CR3","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2016039","volume":"38","author":"N Plato","year":"2016","unstructured":"Plato N, Martinsen JI, Spar\u00e9n P et al (2016) Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban. Epidemiol Health 38:e2016039. https:\/\/doi.org\/10.4178\/epih.e2016039","journal-title":"Epidemiol Health"},{"issue":"10","key":"2168_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2471\/BLT.11.086678","volume":"89","author":"V Delgermaa","year":"2011","unstructured":"Delgermaa V, Takahashi K, Park EK et al (2011) Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89(10):716\u2013724. https:\/\/doi.org\/10.2471\/BLT.11.086678","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2168_CR5","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1378\/chest.122.6.2224","volume":"122","author":"S Metintas","year":"2002","unstructured":"Metintas S, Metintas M, Ucgun I et al (2002) Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 122(6):2224\u20132229. https:\/\/doi.org\/10.1378\/chest.122.6.2224","journal-title":"Chest"},{"issue":"1\u20132","key":"2168_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/19338244.2018.1467873","volume":"74","author":"S Metintas","year":"2019","unstructured":"Metintas S, Ak G, Metintas M (2019) A review of the cohorts with environmental and occupational mineral fiber exposure. Arch Environ Occup Health 74(1\u20132):76\u201384. https:\/\/doi.org\/10.1080\/19338244.2018.1467873","journal-title":"Arch Environ Occup Health"},{"issue":"2","key":"2168_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V et al (2016) World Health Organization Committee for tumors of the pleura, the 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol 11(2):142\u2013154. https:\/\/doi.org\/10.1016\/j.jtho.2015.11.005","journal-title":"J Thorac Oncol"},{"issue":"14","key":"2168_CR8","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644. https:\/\/doi.org\/10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"issue":"18","key":"2168_CR9","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27(18):3007\u20133013. https:\/\/doi.org\/10.1200\/JCO.2008.20.3943","journal-title":"J Clin Oncol"},{"issue":"8","key":"2168_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D et al (2011) MARS trialists, extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12(8):763\u2013772. https:\/\/doi.org\/10.1016\/S1470-2045(11)70149-8","journal-title":"Lancet Oncol"},{"key":"2168_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canep.2019.03.014","volume":"60","author":"N LeStang","year":"2019","unstructured":"LeStang N, Bouvier V, Glehen O et al (2019) Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: a population-based study. Cancer Epidemiol 60:106\u2013111. https:\/\/doi.org\/10.1016\/j.canep.2019.03.014","journal-title":"Cancer Epidemiol"},{"key":"2168_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lungcan.2021.11.001","volume":"162","author":"P Baas","year":"2021","unstructured":"Baas P, Daumont MJ, Lacoin L et al (2021) Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013\u20132017: a nationwide CAS registry analysis from the I-O optimise initiative. Lung Cancer 162:185\u2013193. https:\/\/doi.org\/10.1016\/j.lungcan.2021.11.001","journal-title":"Lung Cancer"},{"issue":"6","key":"2168_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1183\/09031936.01.00275301","volume":"18","author":"E Brambilla","year":"2001","unstructured":"Brambilla E, Travis WD, Colby TV et al (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18(6):1059\u20131068. https:\/\/doi.org\/10.1183\/09031936.01.00275301","journal-title":"Eur Respir J"},{"issue":"2015","key":"2168_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP et al (2015) Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 10(2015):1240\u20131242. https:\/\/doi.org\/10.1097\/JTO.0000000000000663","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2168_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG et al (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142(1):89\u2013108. https:\/\/doi.org\/10.5858\/arpa.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2168_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","volume":"15","author":"AG Nicholson","year":"2020","unstructured":"Nicholson AG, Sauter JL, Nowak AK et al (2020) EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol 15(1):29\u201349. https:\/\/doi.org\/10.1016\/j.jtho.2019.08.2506","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2168_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V et al (2016) World Health Organization committee for tumors of the pleura, the 2015 World Health Organization classification of tumors of the pleura, advances since the 2004 classification. J Thorac Oncol 11(2):142\u2013154. https:\/\/doi.org\/10.1016\/j.jtho.2015.11.005","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2168_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0954-6111(99)90318-9","volume":"93","author":"M Metintas","year":"1999","unstructured":"Metintas M, Ozdemir N, Hillerdal G et al (1999) Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med 93(5):349\u2013355. https:\/\/doi.org\/10.1016\/s0954-6111(99)90318-9","journal-title":"Respir Med"},{"key":"2168_CR19","unstructured":"https:\/\/data.tuik.gov.tr\/Kategori\/GetKategori?p=Nufus-ve-Demografi-109. Accessed 26 Aug 2021"},{"issue":"6","key":"2168_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1378\/chest.09-0884","volume":"137","author":"M Metintas","year":"2010","unstructured":"Metintas M, Ak G, Dundar E et al (2010) Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 137(6):1362\u20131368. https:\/\/doi.org\/10.1378\/chest.09-0884","journal-title":"Chest"},{"key":"2168_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/CLEP.S105396","volume":"8","author":"JL Beebe-Dimmer","year":"2016","unstructured":"Beebe-Dimmer JL, Fryzek JP, Yee CL et al (2016) Mesothelioma in the United States: a surveillance, epidemiology, and end results (seer)-medicare investigation of treatment patterns and overall survival. Clin Epidemiol 8:743\u2013750. https:\/\/doi.org\/10.2147\/CLEP.S105396","journal-title":"Clin Epidemiol"},{"issue":"3","key":"2168_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/10773525.2018.1470789","volume":"23","author":"S Metintas","year":"2017","unstructured":"Metintas S, Ak G, Bogar F et al (2017) Asbestos knowledge and awareness level in central part of Anatolia. Int J Occup Environ Health 23(3):243\u2013249. https:\/\/doi.org\/10.1080\/10773525.2018.1470789","journal-title":"Int J Occup Environ Health"},{"issue":"4","key":"2168_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","volume":"260","author":"DJ Sugarbaker","year":"2014","unstructured":"Sugarbaker DJ, Richards WG, Bueno R (2014) Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann Surg 260(4):577\u2013580. https:\/\/doi.org\/10.1097\/SLA.0000000000000903","journal-title":"Ann Surg"},{"issue":"10","key":"2168_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","volume":"5","author":"CQ Cao","year":"2010","unstructured":"Cao CQ, Yan TD, Bannon PG et al (2010) A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 5(10):1692\u20131703. https:\/\/doi.org\/10.1097\/JTO.0b013e3181ed0489","journal-title":"J Thorac Oncol"},{"issue":"12","key":"2168_CR25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","volume":"11","author":"VW Rusch","year":"2016","unstructured":"Rusch VW, Chansky K, Kindler HL et al (2016) IASLC Staging and Prognostic Factors Committee, advisory boards, and participating institutions, the IASLC mesothelioma staging project: proposals for the m descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J Thorac Oncol 11(12):2112\u20132119. https:\/\/doi.org\/10.1016\/j.jtho.2016.09.124","journal-title":"J Thorac Oncol"},{"key":"2168_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12885-015-1519-z","volume":"15","author":"G Ak","year":"2015","unstructured":"Ak G, Metintas S, Akarsu M et al (2015) The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma. BMC Cancer 15:510. https:\/\/doi.org\/10.1186\/s12885-015-1519-z","journal-title":"BMC Cancer"},{"issue":"8","key":"2168_CR27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","volume":"14","author":"JS Friedberg","year":"2019","unstructured":"Friedberg JS, Culligan MJ, Tsao AS et al (2019) A proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the joint national cancer institute-international association for the study of lung cancer-mesothelioma applied research foundation taskforce. J Thorac Oncol 14(8):1343\u20131353. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.029","journal-title":"J Thorac Oncol"},{"issue":"Suppl 1","key":"2168_CR28","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","volume":"73","author":"I Woolhouse","year":"2018","unstructured":"Woolhouse I, Bishop L, Darlison L et al (2018) British thoracic society guideline for the investigation and management of malignant pleural mesothelioma. Thorax 73(Suppl 1):i1\u2013i30. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321","journal-title":"Thorax"},{"issue":"12","key":"2168_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145039","volume":"10","author":"E Taioli","year":"2015","unstructured":"Taioli E, Wolf AS, Camacho-Rivera M et al (2015) Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients. PLoS ONE 10(12):e0145039. https:\/\/doi.org\/10.1371\/journal.pone.0145039","journal-title":"PLoS ONE"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02168-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T04:05:22Z","timestamp":1655697922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02168-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02168-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}